Home>Topics>Companies>IMS Health

IMS Health RX

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. French drugs market to shrink in 2012 - study

      Headlines

      Thu, 29 Mar 2012

      PARIS, March 29 (Reuters) - France's drugs market is set to shrink in 2012 for the first time, hit by government austerity measures to curb healthcare spending, according to a study published by pharmaceutical intelligence firm IMS Health .

    2. Vertex Pharmaceuticals ([[VRTX]] -8.1%) gets hit after data from IMS Health shows flat sales in September and the first week of October for the company's hepatitis C drug Incivek.

      Headlines

      Mon, 17 Oct 2011

      Vertex Pharmaceuticals ( VRTX -8.1% ) gets hit after data from IMS Health shows flat sales in September and the first week of October for the company's hepatitis C drug Incivek. Post your comment!

    3. UPDATE 1-IMS revises Incivek drug data; Vertex shares jump

      Headlines

      Thu, 13 Oct 2011

      Oct. 13 (Reuters) - IMS Health , which provides prescription data and other services to the pharmaceutical industry, said it is revising estimates of the number

    4. Generic Drugs Continue To Challenge Big Pharma

      Headlines

      Fri, 23 Sep 2011

      decade. It commissioned an independent study, which was conducted by the IMS Institute for Healthcare Informatics and IMS Health . The report will no doubt get attention on Capital Hil and the GPhA is already calling on the budget "Super Committee

    5. PPD Names New CEO

      Commentary

      Mon, 19 Sep 2011

      Raymond H. Hill joined PPD as chief executive officer and a member of the board last week. He previously was president of IMS Health 's Consulting Group, which is a leading health-care industry consultant. Hill's experience as a consultant in

    6. Drug spending slows: IMS

      Headlines

      Tue, 19 Apr 2011

      NEW YORK (Reuters) - Spending growth on prescription drugs slowed to 2.3 percent in 2010 -- the second lowest level in 55 years, according to a report by IMS Health .

    7. Asian Emerging Markets Will Grow On You

      Headlines

      Fri, 25 Feb 2011

      intensifying, but we are maintaining our drug-distribution growth forecasts until we see solid evidence to the contrary. IMS Health RX reported February prescription growth of 1.2%, down from 1.4% in January, and lowered its 2003 and 2004 growth

    8. Our Take on the Fourth Quarter

      Headlines

      Thu, 31 Dec 2009

      leader with a nearly 20% gain. A wide range of software firms led the sector to strong gains in the quarter, including IMS Health RX (+38%), Wipro WIT (+25%), and Salesforce.com CRM (+30). The market is betting that improved corporate

    9. 20 High-Quality, Cheap Stocks for Last-Minute Shoppers

      Headlines

      Thu, 24 Dec 2009

      didn't match the market's returns. Still, 12 constituents posted positive returns during their three-month run. IMS Health RX led the group with a 33.2% return between Sept. 21 and Dec. 18. In early November, IMS agreed to be acquired

    10. Increasing IMS Health's Uncertainty

      Commentary

      Fri, 18 Dec 2009

      While we remain upbeat about the long-term prospects for IMS Health RX, we are increasing our uncertainty rating for the company to high from medium in light of the recent legislative initiatives

    « Prev12345Next »
    Content Partners